Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer

BACKGROUND: Neoadjuvant stereotactic body radiotherapy (SBRT) has potential applicability in the management of borderline resectable and locally-advanced pancreatic adenocarcinoma. In this series, we report the pathologic outcomes in the subset of patients who underwent surgery after neoadjuvant SBR...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Radiat Oncol
Hoofdauteurs: Rajagopalan, Malolan S, Heron, Dwight E, Wegner, Rodney E, Zeh, Herbert J, Bahary, Nathan, Krasinskas, Alyssa M, Lembersky, Barry, Brand, Randall, Moser, A James, Quinn, Annette E, Burton, Steven A
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2013
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4228466/
https://ncbi.nlm.nih.gov/pubmed/24175982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-8-254
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items